{
    "title": "UPDATE 3-Merck to slim down with asset spinoff, focus on Keytruda, vaccines",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-7969463/Merck-spin-womens-health-biosimilar-products-Keytruda.html",
    "date": "2020-02-05",
    "keywords": [
        "merck",
        "company",
        "growth",
        "spinoff",
        "cancer",
        "keytruda",
        "frazier",
        "succession",
        "erman",
        "health",
        "half",
        "management",
        "inc",
        "wednesday",
        "biosimilar",
        "focus",
        "drug",
        "treat",
        "business",
        "care",
        "bridion",
        "anesthesia",
        "drugmaker",
        "culmination",
        "strategy",
        "immunotherapy",
        "selling",
        "executive",
        "interview",
        "key",
        "mainstay",
        "lung",
        "opportunity",
        "oncology",
        "attention",
        "ali",
        "veteran",
        "transaction",
        "dividend",
        "entity",
        "debt",
        "forecast",
        "cost",
        "announcement",
        "color",
        "concern",
        "cantor",
        "analyst",
        "louise",
        "chen",
        "policy",
        "step",
        "age",
        "year",
        "helm",
        "board",
        "process",
        "place",
        "today",
        "term",
        "profit",
        "share",
        "penny",
        "reporting",
        "bengaluru",
        "michael",
        "york",
        "editing",
        "maju",
        "samuel",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}